Heart Failure Flashcards

Nicolas Norgard, PhD. (UMKC)

1
Q

Ways to diagnose heart failure?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HFpEF

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Neurohormonal model that drives heart failure

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HFrEF

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

AHA HF Classification

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

NYHF Classification

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Criteria for diagnosing heart failure

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Brain Natriuretic Peptide (BNP)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

First step in treatment of HF

A

Beta Blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Second step in treatment of HF

A

Vasodilating Beta Blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Choice of beta blockers to use for treatment of HF?

A

Carvedilol
Bisproprolol
Metoprolol succinate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Is carvedilol or metoprolol more effective?

A

Carvedilol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Temporal Effects of Beta Blocker Treatment in Heart Failure

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Best way to dose beta blockers?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Uses of Ivabradine?

A

Add onto beta blockers if dose is maxed out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Third step in treatment of HF after beta blockers are on board?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Overview of the Renin-Angiotensin-Aldosterone System Blockade

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Biological effects of angiotensin II?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Major effects of ACE inhibitors?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Dosing of ACE inhibitors?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When to use an angiotensin receptor blocker (ARB)?

A
22
Q

Use of Neprilysin inhibitors?

A

Add onto an ARB, do not use with ACEi

23
Q

Use of aldosterone antagonist?

A
24
Q

Use of hydralazine and nitrates?

A
25
Q

Effectiveness of hydralazine/Isorbide dinitrate among race?

A

Use in black patients:

  • Added to, not substituted for ACE inhibitors or ARB
  • Recommended for black HF patients who remain symptomatic despite optimal medical treatment
  • Appropriate as first-line therapy in all HF patients unable to tolerate either an ACE inhibitor or ARB because of renal insufficiency, hyperkalemia, or possibly hypotension
26
Q

Use of diuretics in HF patients?

A
27
Q

Dosing of diuretics?

A
28
Q

Mechanism of action in the kidney of loop and thiazide diuretics?

A
29
Q

Appropriate treatment for the following patient?

A
30
Q

Treatment for a patient that is experiencing over-diuresis?

A

Digoxin?

31
Q

Risks of using digoxin?

A
32
Q

Modes of death dependent upon HF classification?

A
33
Q

What is Cardiac Resynchronization Therapy (CRT)

A
34
Q

Implantable Cardioverter-Defibrillator (ICD)

A
35
Q

Indication for Cardiac Resynchronization Therapy (CRT)?

A
36
Q

Left ventricular assist device?

A
37
Q

Specific contraindications for cardiac transplantation?

A
38
Q

Treatment for Heart Failure with Reduced Ejection Fraction?

Risks…

A
39
Q

Prevalence of Heart Failure with Preserved Ejection Fraction (HFpEF)?

A
40
Q

Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)?

A
41
Q

Acute heart failure syndromes (AHFS)

A
42
Q

Medical management of AHFS is based on precipitating factors and clinical presentation

A
43
Q

In patients experiencing a HF exacerbation requiring hospitalization:

Acute heart failure syndromes (AHFS)

A
44
Q

Acute Heart Failure Syndromes: Medical management of AHFS is based on precipitating factors and clinical presentation

A
45
Q

Monitoring with a Swan-Ganz Catheter?

A
46
Q

How to help HF patients in the warm and wet category?

A
47
Q

Treatment for HF patients in the cold and wet category?

A
48
Q

Selection of an inotrope?

A
49
Q

Effectiveness of different inotropes?

A
50
Q

Flow chart for HF patients:

A